Chembio Diagnostics to Report Third Quarter 2021 Financial Results on November 4, 2021
October 21 2021 - 4:50PM
Chembio Diagnostics, Inc. (Nasdaq: CEMI), a leading point-of-care
diagnostics company focused on infectious diseases, announced today
that it will release financial results for the third quarter of
2021 after the close of trading on Thursday, November 4, 2021.
The company’s management team will host a corresponding
conference call beginning at 4:30 p.m. Eastern Time on November 4,
2021. Investors interested in listening to the conference call may
do so by dialing 888-506-0062 from the US or 973-528-0011 from
outside the US and providing Entry Code: 938540 or by accessing
www.chembio.com/investors/calendar-of-events/. A replay of the call
will be available by dialing 877-481-4010 from the US or
919-882-2331 from outside the US using passcode 43155 or by
accessing www.chembio.com/investors/calendar-of-events/.
About Chembio DiagnosticsChembio is a leading
point-of-care diagnostics company focused on detecting and
diagnosing infectious diseases, including COVID-19, sexually
transmitted disease, and fever and tropical disease. Coupled with
Chembio’s extensive scientific expertise, its novel DPP technology
offers broad market applications beyond infectious disease.
Chembio’s products are sold globally, directly and through
distributors, to hospitals and clinics, physician offices, clinical
laboratories, public health organizations, government agencies, and
consumers. Learn more at www.chembio.com.
Investor contact:
Philip TaylorGilmartin Group(415) 937-5406investor@chembio.com |
|
Chembio Diagnostics (NASDAQ:CEMI)
Historical Stock Chart
From Sep 2024 to Oct 2024
Chembio Diagnostics (NASDAQ:CEMI)
Historical Stock Chart
From Oct 2023 to Oct 2024